Thank you very much, Madam Chair. I want to thank the witnesses for being here today.
I saw my father suffer from the complications of diabetes, and to see the changes that have occurred just in my lifetime are quite amazing.
Our overall theme of these studies is technology and innovation. We heard from Ms. Sissmore. She talked about the glucose monitor, and I was excited to hear from JDRF here today.
Occasionally, we hear from Dr. Beaudet. He said some recent changes are happening at the institute in terms of reforming the granting systems. I was wondering, what capacity and infrastructure does CIHR have to be responsive to issues like juvenile diabetes, and can this be done efficiently?